BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3549502)

  • 21. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
    Namba M; Matsuyama T; Nonaka K; Tarui S
    Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.
    Holst JJ; Kreutzfeldt M; Holm G; Jensen E; Poulsen JS; Sparsö B; Sparsö B; Schmidt A
    Diabete Metab; 1978 Jun; 4(2):75-9. PubMed ID: 680313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic hormones and plasma glucose: regulation mechanisms in the goose under physiological conditions. II. Glucose-glucagon and glucose-insulin feed-back mechanisms.
    Sitbon G; Mialhe P
    Horm Metab Res; 1978 Mar; 10(2):117-23. PubMed ID: 649038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
    Tanjoh K; Tomita R; Hayashi N
    Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
    Valverde I; Ghiglione M; Matesanz R; Casado S
    Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary and adrenal control of pancreatic endocrine function in the duck. III. Effects of glucose, oleic acid, arginine, insulin and glucagon infusions in hypophysectomized or normal ducks.
    Foltzer C; Mialhe P
    Diabete Metab; 1980 Dec; 6(4):257-63. PubMed ID: 7009247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man.
    Hornnes PJ; Kühl C; Holst JJ; Lauritsen KB; Rehfeld JF; Schwartz TW
    Metabolism; 1980 Aug; 29(8):777-9. PubMed ID: 6995794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The endocrine pancreas of birds].
    Sitbon G; Mialhe P
    J Physiol (Paris); 1980; 76(1):5-24. PubMed ID: 6106057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal insulinotropic hormones in normal and gestational-diabetic pregnancy: response to oral glucose.
    Hornnes PJ; Kühl C; Lauritsen KB
    Diabetes; 1981 Jun; 30(6):504-9. PubMed ID: 7014314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
    Kåresen R; Tronier B; Aune S
    Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of glucagon-like polypeptides in gastrectomized patients transformed from Billroth II into Billroth I.
    Tamburrano G; Mauceri M; Lala A; Tonelli F; Leonetti F; Andreani D
    Horm Metab Res; 1982 Dec; 14(12):642-5. PubMed ID: 7152478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose tolerance and insulin secretion after caudal resection of the pancreas in children.
    Miyata M; Yamamoto T; Okada A; Nakao K; Kawashima Y
    Z Kinderchir; 1982 Jul; 36(3):103-6. PubMed ID: 6750967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.